RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Phoenix, AZ · +119 more sites
1 recruiting psoriasis studies with a site in Tempe, AZ.
Sponsor: Bristol-Myers Squibb
Phoenix, AZ · +119 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.